The cannabis industry is set to maintain its positive trajectory as legalization sweeps throughout the U.S., Europe, and Latin America. For instance, Jefferies Group, an investment bank, predicts that these regions will legalize cannabis for both medical and recreational use in the shortcoming years. Moreover, Jefferies projects that the cannabis industry will also penetrate into various industries such as pharmaceutical, alcohol, health and wellness, and pet supply industries. Notably, Canada made headlines in 2018 after it became the second country to ever legalize cannabis and the first G-7 nation to do so. Additionally, the remaining G-7 nations, with the exception of Japan, have all adopted partial or full medical cannabis programs, while several have decriminalized the recreational use of cannabis. Uruguay was the first country to fully legalize cannabis back in 2013. And while Canada and Uruguayhave both legalized cannabis entirely, the U.S. remains the largest sole market in the industry. Despite not having federally legalized cannabis, the country still delivers billions of dollars in cannabis sales annually, largely thanks to states such as California, Colorado, Nevada, and Washington. Jefferies predicts that less regulated markets can account for nearly USD 80 Billion of the total global cannabis market value. Specifically, Jefferies projects the U.S. cannabis market to reach a value of USD 21.7 Billion by 2029, compared to Canada’s estimate of just USD 5.8 Billion. Additionally, the estimated value is added onto Jefferies’ base valuation for the global cannabis industry of USD 50 Billion by 2029, a figure that accounts for the countries that have already legalized cannabis for either medical or recreational use. As a result, Jefferies forecasts that the total global legal cannabis industry is positioned to reach USD 130 Billion by 2029. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), HEXO Corp. (NYSE-A: HEXO) (TSX: HEXO), Charlotte’s Web Holdings, Inc. (OTC: CWBHF) (TSX: CWEB), The Supreme Cannabis Company, Inc. (OTC: SPRWF) (TSX: FIRE), Emerald Health Therapeutics Inc. (OTC: EMHTF) (TSX-V: EMH)
While the legal cannabis industry is growing worldwide, the black market is still heavily prevalent in many regions. Jefferies’ analysts accounted for the global illicit market in its research, which the firm estimated it to be valued at around USD 150 Billion to USD 200 Billion. Jefferies’ estimates note that the overall cannabis market, including both legal and illicit channels, would be currently valued at approximately USD 210 Billion. Jefferies did also mention that the eradication of the black market would take some time because it would require global legalization. Nonetheless, the number of consumers purchasing from the black market have dwindled in regions where cannabis is legalized. For instance, during Canada’s first quarter of legalization, it was reported that an estimated 47% of cannabis users or 2.5 million Canadians purchased their supply from a legal vendor, which has more than doubled year-over-year, according to Statistics Canada. Many companies within the cannabis marketspace have also made it their mission statement to eliminate illicit sources and provide consumers with high-quality products. For this reason, cultivators have engaged in advanced growing methods and techniques to outshine the black market. In recent years, cultivators have practiced the artisanal profession of growing “craft cannabis,” which is known to be a meticulous process of growing cannabis. Craft cultivators pride themselves on premium and naturally grown cannabis that stands out when compared to large-scale producers and illegal vendors. To emphasize, craft cultivators stray away from artificial byproducts such as pesticides to create a more organic end product. By avoiding the use of pesticides, cultivators are required to tend to each individual plant to avoid molding or infestations, while the attentive procedure also ensures that each and every plant grows high-quality buds. While craft cannabis is generally costlier than wholesale-produced cannabis, the quality between the two is drastically different. Generally, craft cultivators engage more hands-on, meaning that plants are hand-trimmed and carefully packaged to assure that the buds are intact and maintain their cannabinoids. “Large-scale production has such a negative connotation right now that everyone is rushing to be ‘craft’ or ‘small-batch’ or ‘artisanal,'” Jake Browne, Co-Founder of The Grow-Off said. “In reality, a lot of this product [large-scale producers] is machine trimmed and packed by temp workers barely making minimum wage.”
Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT) is also listed on the Canadian Securities Exchange under the ticker (CSE: CRFT). Earlier last month, the Company announced the “addition of three well-respected cannabis experts to the growing Pasha family: Scientific researcher Dr. Cris Felipe Alves, second-generation cultivator and consultant Travis Lane, and lifelong cultivator Kemal Morris.
As a solution provider to the craft cannabis industry, Pasha subsidiary BC Craft Supply Co. Ltd. (“BC Craft Supply”) aims to provide cannabis farmers with the tools to transition to new regulations governing the micro-cultivation licence category. These experts will assist farmers in making that transition.
‘I’m thrilled to have these experts join our team, and, with their support, I look forward to disrupting the market with craft products that will help solve Canada’s ongoing supply chain issues,’ said Patrick Brauckmann, Executive Chairman of Pasha Brands. ‘With these additions to the Pasha family, I’m confident that enthusiasm for craft products will continue to grow.’
Dr. Cris Felipe-Alves has worked in academic and commercial settings in Australia, Asia, and North and South America, and holds a B.Sc in Biological Sciences from the University of Brasília, and a PhD in Molecular Biology and Biochemistry from Nagoya University. While working as a senior scientist at a global diagnostics company, he led a team of researchers from discovery to R&D and sales of molecular tools designed to detect cancers non-invasively. During this time, he became interested in the potential for cannabis as a curative agent against several types of cancer. Since then, he has worked as an extraction specialist and a Quality Assurance Manager. He will act as the Senior Quality Assurance Person at BC Craft Supply.
‘Here at Pasha, I feel at home and am proud to be part of a brand house that has a focus on craft products,’ said Dr. Felipe-Alves. ‘I look forward to helping Pasha generate safe and efficient cannabis-based products that suit the needs of both recreational and medical consumers both in Canada and around the world.’
Renowned cultivator and consultant Travis Lane has been growing cannabis for more than 20 years. An organic, living-soil-based cultivator who has advocated for the facilitation of pesticide-free, sun-grown cannabis production, Lane has been involved in the founding of numerous small cannabis businesses over the last decade, including a successful chain of storefront dispensaries, a thriving online mail order service, and was a founding partner in one of the most successful hydrocarbon extraction brands in the country. Under legalization, Lane has divested from the illicit market to focus on multiple Cannabis Act license applications, as well as his work with Groundwork Consulting, focused on government relations and licensing for cultivation and retail, and Levity Solutions, a multi-purpose cannabis consultancy focused on assisting aspiring legal cultivators. He will act as a consultant for Pasha Brands and its subsidiaries.
‘The level of talent and expertise that exists in the prohibition-era marketplace is beyond impressive,’ said Lane. ‘These long-time innovators will represent a huge market factor once licensed, and I am proud to help Pasha facilitate this next wave.’
Kemal Morris is a lifelong cultivator who has had his hands in the soil ‘since before he could walk’. He watched his parents grow their own food – and cannabis – on Saltspring Island, British Columbia. Soon after Canada launched its first medical cannabis program in 2001, he spent 14 years learning the intricacies of breeding and extract production. In addition, Morris has spent the last four years launching a prominent Canadian Licensed Producer. He is passionate about patients and has connected hundreds of struggling patients with medicine. As the Master Grower for Pasha Brands’ owned Vancouver Island Licensed Producer, MedCann, Morris will act as facility designer, cannabis expert, educator and facilitator.
‘After completing a four-year term in the regulated industry, I am excited to work with Pasha,’ said Morris. ‘I finally have the opportunity to share all that I have learned with the cannabis enthusiasts I came up with, and I’m proud to be part of a company that is breaking the big business mold – affording a rightful place to the people who risked everything to create this thriving industry.’
About Pasha Brands: Based in Vancouver, British Columbia, Pasha is a vertically integrated, prohibition-era brand house firmly rooted in BC’s craft cannabis industry, which boasts an international reputation. With proven capabilities in cannabis cultivation, genetic research and development, product processing, and retail, Pasha is uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers under the Pasha umbrella. Pasha subsidiary, Medcann Health Products Ltd. is a Health Canada licensed cultivator and processor with a licence to sell medical cannabis products in Canada. Pasha and BC Craft are also developing a craft cannabis campus, which is dedicated to bringing craft quality into the newly legal cannabis market in Canada. BC Craft is driven to assist craft growers in obtaining security clearance and licensing to grow as micro-cultivators, specializing in education and compliance to bring growers into the regulated cannabis supply market. Pasha’s common shares trade on the CSE under the symbol “CRFT”. For more information, please visit www.pashabrands.com”
For our latest “Buzz on the Street” Show featuring Pasha Brands Ltd. recent corporate news, please head over to:
HEXO Corp. (NYSE-A: HEXO) (TSX: HEXO) is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. HEXO Corp. and Newstrike Brands Ltd. recently announced that they had entered into a definitive arrangement agreement under which HEXO will acquire, by way of a plan of arrangement under the Business Corporations Act (Ontario), all of Newstrike’s issued and outstanding common shares in an all-share transaction valued at approximately USD 263 Million. The Transaction gives HEXO the capacity to produce approximately 150,000 kg of high-quality cannabis annually. The Transaction also provides HEXO access to four cutting-edge production campuses totalling close to 1.8 million sq. ft. of near-term cultivation space and diversified growing and production techniques. This is in addition to HEXO’s 579,000 sq. ft. facility for a manufacturing and product development center of excellence in Belleville, Ontario. Combined, HEXO and Newstrike have established distribution agreements in 8 provinces including Ontario, Quebec, British Columbia, Alberta, Saskatchewan, Manitoba, Nova Scotia, and Prince Edward Island, allowing broad consumer access to HEXO’s products across Canada. Newstrike’s licensed indoor facility provides HEXO with access to diversified growing techniques and positions HEXO for flexibility for international exports as global cannabis markets continue to open. “We’re thrilled to welcome the Newstrike team into the HEXO family. Jay Wilgar, Chief Executive Officer of Newstrike, and his team have built incredible relationships, including teaming up with The Tragically Hip, and they share HEXO’s vision of bringing exceptional branded cannabis experiences to adults everywhere,” said Sebastien St-Louis, Chief Executive Officer and Co-Founder of HEXO Corp. “With Newstrike, we’re adding talented employees and infrastructure to take HEXO to the next level on our journey to become one of the largest cannabis companies in the world. We’re extremely proud of our record of execution, and today are committing to achieving over USD 400 Million in net revenue in 2020.”
Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (TSX: CWEB) is the market leader in the production and distribution of innovative hemp-derived cannabidiol (“CBD”) wellness products. Charlotte’s Web Holdings, Inc. recently reported final hemp planting for its 2019 growing season. In order to meet growing demand from consumer and retail channel partners, total acres planted for 2019 has been increased to 862, an 187% increase from 300 acres planted in 2018. In 2016, 2017 and 2018, the Company produced 41,000 lbs., 63,000 lbs. and 675,000 lbs., respectively, of dried hemp biomass. “Interest and demand for our products has been exceptional and growing rapidly. Our 2019 planting strategy ensures we will have the required raw materials to deliver on production targets for Charlotte’s Web products through 2020 and into 2021,” stated Deanie Elsner, Chief Executive Officer of Charlotte’s Web. “Our leading CBD hemp varieties under cultivation today are the foundation of our 2020 production plan. Tens of thousands of Americans have come to rely on Charlotte’s Web products daily making it essential that our products are always available, efficacious and consistent day-to-day, bottle-to-bottle, year-to-year.”
The Supreme Cannabis Company, Inc. (OTCQX: SPRWF) (TSX: FIRE), is a globally diversified portfolio of distinct cannabis companies, products and brands. The Supreme Cannabis Company, Inc., in partnership with Khalifa Kush Enterprises Canada ULC, recently launched KKE Oil, the first product under the KKE brand line. KKE Oil is a premium, recreational focused oil, developed for the consumer who wants the convenience, high THC potency and precise dosing offered by a cannabis oil. KKE Oils are one of the first ever recreational-focused cannabis oils available to consumers in Canada. Wiz Khalifa and the KKE team specifically selected the Supreme Cannabis’ wholly-owned subsidiary, 7ACRES Sensi Star strain for the debut of the line. “We firmly believe that a high-quality input supports high-quality output and KKE Oil embodies this belief. We are excited to launch one of the first recreational focused cannabis oils in Canada with Wiz Khalifa and the KKE team. KKE Oils are easy to consume, effective and deliver the aromatic terpene profile 7ACRES’ Sensi Star is known for. We can’t wait to launch the full suite of KKE products, including KKE Jean Guy Oil, later this year,” said John Fowler, President and Founder of Supreme Cannabis.
Emerald Health Therapeutics Inc. (OTCQX: EMHTF) (TSX-V: EMH) is a Canadian licensed producer of cannabis. Emerald Health Therapeutics, Inc. recently reported that is had expanded its agreement to purchase harvested hemp flower and leaf, or hemp chaff, from Emerald Health Hemp Inc. (“EHH”) from 1,000 to 1,200 acres for 2019. EHH is a wholly owned subsidiary of Emerald Health Sciences Inc. and a related party of Emerald. Based on last year’s harvest, Emerald expects production from the 1,200 acres to be at least 270,000 kg of hemp chaff in 2019 with, conservatively, approximately 2% cannabidiol (“CBD”) content. Emerald estimates that this hemp may yield 3,500 kg of extracted CBD, which it plans to use to manufacture premium oils, softgels and associated value-added products for Canadian adult-use and medical consumers. “Emerald, through its partnership with the Factors Group and their scalable processing capacity, is uniquely situated to become one of Canada’s leading producers of premium CBD products from hemp,” said Dr. Avtar Dhillon, President and Executive Chairman. “We established our first-mover advantage in 2018 by securing hemp on a large scale and gaining production insights that will benefit us in 2019. With even more supply contracted for this year, we expect significant near-term growth in this market segment.”
Is It Safe To Drive On CBD?
Safe driving requires sharp skills and the right state of mind. How you drive the car depends on a lot of conditions. From feeling dozy, being under the influence of alcohol to experiencing anxiety from mental issues, all sorts of things can mess up your control at the wheel. Cannabis consumption also becomes part of this list due to its ability to make you “high,” thereby thwarting your response. While Cannabis contains some psychoactive compounds, Hemp, which is a strain of Cannabis Sativa, is mostly free of such compounds and is legal for consumption. It’s worth a closer look to understand if CBD, which is a compound found in Hemp, really sucks if taken before your driving session.
Can CBD trouble you while driving?
CBD or “cannabidiol” is a chemical compound widely found in the Hemp strain of Cannabis. While Cannabis has a big impression of being “mind-altering,” it is primarily due to the presence of THC compound.
CBD has a negligible quotient of THC in it and hence is not considered psychoactive. But that doesn’t mean it is entirely okay to drive on CBD since it can have some other effects on your body. So the answer is: it depends on the consumer.
If you are accustomed to taking CBD, then it won’t be a problem in most of your activities. However, if you are only starting, observe how you hold up on CBD before you crank up the engine.
Most of the marketed CBD supplements carry less than 0.3% THC element in them, which makes them risk-free. This level of THC can’t produce any significant mind-altering effect, which can cause harm while driving.
Can CBD help you while driving?
CBD is a Cannabinoid which is being gradually explored by researchers due to its medicinal values. Studies suggest that CBD can help us cope with several issues in our day to day life like inflammation, obesity, indigestion, etc.
CBD’s organic nature works positively with the human body’s Endocannabinoid system and provides various benefits to the body. It can regulate certain chemicals in the human body and thereby lift your mood and relieve you of anxiety.
CBD oil and pills are also an excellent replacement for the regular allopathic doses, which come with a lot of side-effects that may curtail your physical abilities. The easiest way to get familiar with CBD and test your tolerance level is by having a taste of CBD Pills. The pills are convenient as you can simply swallow them and continue with your daily chores.
How should you approach CBD if you are one who is often at the wheel?
Users consume CBD in multiple ways. From vape to pills, tinctures, and gummy bears- CBD’s multifaceted form makes it a popular substance for people of all ages. Since CBD is a new phenomenon for most people who are not well-educated about it, they usually confuse CBD with the psychoactive THC element, which is quite dominating in its influences. The truth is that CBD’s extraction process is entirely independent of THC, and there is no reason you should confuse the two.
Different products derived from CBD compound have different levels of impact. A pill may take many hours to make you feel relaxed while also lasting for a longer time. On the other hand, skin lotion or even an injected solution of CBD can prove its effects reasonably quickly but may soon lose its influence. So you should judge your circumstances and choose the way which suits you best.
Here are some points to keep in mind if you are a driver and have decided to embrace CBD:
- If you are a long-time consumer of Cannabis products, there is no reason for you to bother. CBD may relax you, but it is not going to intoxicate you in any way. So you will be in the best of states to handle the steering.
- If you are a newbie and have never consumed anything related to Cannabis, relax; CBD is not going to make you “high” like other THC-induced products. However, you may feel lightheaded after taking CBD if you are not much accustomed to it. In such cases, you shouldn’t drive until you feel okay.
- After an intake of CBD for the first time, it is better if there is a co-driver with you in the car who can take control if you feel drowsy.
- CBD has minimal THC content and is harmless in itself. However, you should monitor how you are coping with it and be mindful of the quantity that is suitable for you.
- Although CBD’s source strain Hemp has less than 0.3% THC, the products may bring you legal problems if you travel abroad with those. Most governments allow a THC volume ranging between 0.2-0.6%, but you should be sure about the local rules before you hit the road.
- If you are still concerned about your post-CBD driving sessions, search for CBD products that are certified to contain 0% THC. Click here to know more about the cbd.
Final suggestions for drivers willing to try CBD:
The recent studies and experiments on Cannabis have brought several positive results. As the medicinal values of Cannabis are getting more and more acceptance on a global level, the apprehensions regarding it are also decreasing. One should understand that there are different varieties of Cannabis, and people use them in different ways based on their needs. If you wish to get high, there are different strains for that purpose. Nowadays, hybrid strains are developed to give different results to users.
As far as CBD goes, it is by far the safest option in the world of Cannabis. One of the reasons for CBD’s increasing popularity is its flexible usability. CBD can be used as edible oil, capsules, or even lotions. Combine its utility, easy availability, and legal permissibility; you have a substance that can make life comfortable without severe consequences.
While most of the studies on CBD are at their initial stages, it is safe to say that if taken in a specified dosage regularly, CBD can help people cope with particular mental and physical issues. Everything said you should remember that driving is a serious task that asks for all your concentration. Hence, it will be prudent to go slow and understand your tolerance level so that there are no harsh effects. You can always consult your doctor to check the initial impacts of CBD solutions on your body. A steady start will help you drive “high” in the long run!
Cannabis Can Treat Epileptic Seizures
Cannabis has been used for millennia to treat many conditions. It has long been known that cannabis can help with pain, depression, and was even used in ancient China as an anesthetic for surgery.
It has also been recognized millennia ago as a potential treatment for epilepsy. However, it wasn’t until recently that we have had the scientific studies to back those beliefs up.
It all began with a girl named Charlotte Figi. Charlotte has a rare form of epilepsy known as Dravet Syndrome. At just three months old, Charlotte had her first seizure. The seizure lasted half an hour. It only got worse from there; as Charlotte got older, the number and severity of her daily seizures increased. Some of the seizures lasted up to four hours.
By the time that Charlotte was two, she began showing signs of cognitive decline and displaying signs of autistic behavior. She had aggressive outbursts, would injure herself, and was reluctant to make eye contact. At one time, Charlotte was having up to three hundred grand mal seizures a week, despite being on heavy duty anti-seizure medications. At times, her heart stopped during the seizures. Charlotte’s parents and doctors eventually put her into a medically induced coma to allow her to recuperate. They even signed a do-not-resuscitate order in the event that something went horribly wrong.
Then, Charlotte’s grandfather started reading several success stories from parents who were using cannabis to treat their children’s seizures. Another boy with Dravet’s Syndrome and his story stood out. Charlotte’s doctors had said that they had done all they could. In desperation, her parents got a hold of some R4 cannabis extract oil for Charlotte. A miracle occurred. Charlotte went from 300 seizures a week to zero seizures during her first week of treatment. Seeing that the cannabis treatment was helping, Charlotte’s parents reached out to the Stanley Brothers, who run medical marijuana farms and dispensaries in Colorado. They created Charlotte’s Web, a hybrid strain of medical marijuana, which contained a 30:1 mixture of CBD to THC.
After Charlotte’s success story came a number of others. All from parents whose children were helped by Charlotte’s Web and other high-CBD cannabis treatments. Anecdotal stories are one thing, but is there scientific evidence? The answer to that is yes.
In 2016, Orrin Devinsky, a neurologist at New York University Langone Medical Center and colleagues across multiple research centers published the results from a study of a cannabis-based drug for treatment-resistant epilepsy in the journal Lancet Neurology. 162 patients were treated with an extract of 99% cannabidiol (CBD) and monitored them for 12 weeks. The treatment was given in conjunction with existing medications.
The results were more than promising. The treatment resulted in the reduction of motor seizures that was comparable to similar drugs. 2% of patients reported being seizure- free. The trial led by Devinsky was the most robust assessment of CBD’s effect on epilepsy. Unfortunately, these trials were open trials and had no controlled factors.
However, more recently, the Food and Drug Administration approved a highly purified oral preparation of CBD. In the open label expanded access programs as well as placebo-controlled trials, there was a significant improvement in seizure frequency when compared to the placebo patients with Dravet Syndrome and Lennox-Gastaut Syndrome. The drug that has been approved by the FDA is the prescription medication known as Epidolex.
The results from the gold-standard studies of Epidolex were extremely promising. In the group receiving 20 mg of CBD twice daily, the occurrence of seizures dropped 41.9%. In those receiving the 10 mg dose, seizures dropped by 37.2%. In the placebo group, seizures dropped by 17.2%. Like with all other medications, even treatment with CBD oil has its side effects. For the most part, the side effects are well tolerated and only a few patients experienced side effects serious enough to stop taking the medication. The most commonly reported side effects were sedation, decreased appetite, and diarrhea.
When it comes to the legality of CBD treatments, especially those not approved by the FDA, there is good news. The passage of the 2018 Farm Bill hemp and hemp-derived substances are exempt from the Controlled Substances Act. This includes CBD oil, which can be purchased at places like TheAmsterdam. Even though it has been legalized, it is important that any parent or patient speak with their doctors before beginning any treatment.
Addressing THC Detox Myths and Facts
Cannabis is a popular drug. Slowly it’s becoming more socially acceptable for people of all ages. But that doesn’t mean marijuana is safe, especially in terms of detoxing.
There are several myths concerning THC detox; so much so that many users perform it without any health concerns.
Below is a list of THC detox myths and facts to consider. But before that, here’s a brief explanation of what detoxing is.
THC Detox: What Is Detoxing?
As you abstain from consuming marijuana, your body is able to flush THC out of the system. While the process could be easy for some, others may find it difficult; it mostly depends on how heavily one has been consuming marijuana and whether or not they were doing it for medical purposes.
Some of the side effects of THC detox are as follows:
- Loss of appetite, etc.
Usually, it takes up to 15 days before your system is clean—that is if you’re an occasional user. However, reports suggest that heavy users should abstain from pot usage for about 77 days. Now, if you have a drug test next week at the office, it’s likely to try some unusual things to cheat the test—this is where we cue in.
Here are some common myths and facts regarding THC detox you should know about.
Myth no. 1: All It Takes Is an Ungodly Amount of Water
False. Also referred to as “dilution” or ‘flushing,” this myth indicates that drinking a lot of water dilutes your urine just enough to make THC completely undetectable.
Fact: It’s Dangerous
Excessive water consumption is dangerous and may cause hyperhydration, which, in turn, can also lead to electrolyte disorders. When you dilute urine excessively, it’ll have a decreased specific creatinine and gravity level—both of these are identified during the drug testing process.
Myth no. 2: Fake Urine is Key
No. You will find a bunch of firms selling synthetic urine online. As far as stories go, some people have claimed to use chicken broth as a substitute, even though it lacks all of the chemical properties of urine.
Fact: Lab Test Are No Joke
It would be silly to assume that a highly trained lab specialist will be tricked by chicken noodle soup broth. The chemical properties and analysis are sure to catch you, if not the smell. And it’s the same story with fake urine.
Myth no. 3: Natural Diuretics Help to Flush Toxins Out of the System
Diuretics are essentially substances that boost urine production, as well as output. Some of the most popular diuretics are tea, coffee, cranberry juice, beer, and pretty much any beverages with caffeine. Furthermore, there are medications like Modil or Lasix that claim to work.
Fact: They Do Not Eliminate Toxins
While diuretics can make you urinate, they don’t eliminate THC. Of course, they can remove toxins from your body and reduce metabolites’ concentration in urine. However, the consumption of diuretic is similar to drinking plenty of water concerning detox purposes.
Myth no. 4: Intense Exercise Is the Answer
THC is stored in the fat cells of our body. Therefore, the more body fat one has, the longer it will take to detox. Solid exercise like resistance training and cardio can burn fat and boost your metabolism.
Fact: It’s Not a Short-Term Fix
You must exercise on a regular basis to stay healthy, fit, and make sure your weight is under control. But it’s by no means a magic “THC detox getaway card.” Exercising regularly may help to pass the test, but keep in mind that it’s a slow process; not one that can be achieved overnight.
Myth no. 5: “I am only a passive smoker.”
When everything else fails, some people claim to be in a room full of heavy smokers; hence they did not pass the drug test. As interesting as it may sound, the world doesn’t work that way.
Fact: You Cannot Inhale Smoke From Other People’s Bong and Use It As Defense
All drug tests have a certain cut-off level. A urinalysis for cannabis, in most cases, has its cut-off point at 50 ng per milliliter, and you simply cannot reach that point through passive inhalation.
So, the time has come for a THC detox. Maybe you have a drug test coming up or decided to take a tolerance break and want to cleanse your body before starting anew. Regardless of the reason, we hope you’ll consider the myths and facts concerning THC detox mentioned in this article. Also, it’s always good to consult with a doctor beforehand.
About the author: Kathrin Garner is an enthusiastic journalist and writes article on social issues. As an activist, she takes part in NCSM program, which is a discussion platform on the relevant cannabis topics. So, if you want to know how to detox from weed, feel free to contact her. Also, she is a volunteer at Marijuana Detox. She searches for current issues, and writes about it to a wide range of readers.
Subscribe to PICANTE via Email
Follow us on Facebook
Shortages of Low-Skill, Middle-Skill, and High-Skill Workers Causing Revenue Declines and Other Headaches for Employers, TrueBlue’s Latest Study Finds
Law Firm of Estey & Bomberger Reports: Uber Says Nearly 6,000 Rapes, Sexual Assaults Occurred in Two-year Period
Best’s Market Segment Report: AM Best Maintains Global Reinsurance Market Outlook at Stable
Play harnesses ADVA timing solution for 5G-ready mobile network
Japan’s Friendship Ties Programs JENESYS 2019 ASEAN Inbound Program 15th Batch
Alfresco Wins 2019 Aragon Research Innovation Award for Content Management
Mark Your Calendars! Best Buy Unveils 12 Days of Deals
Chorus.ai Wins 2019 Aragon Research Innovation Award for Conversational AI
The 3rd HK Store of “A Happy Pancake” Finally Opens!!
Dynatrace Announces Pricing of Follow-On Offering By Selling Stockholders
Interview with Branislav (“Banne”) Gjorcevski (CEO at IT Labs)
List of iPhone, AirPods, iPad, MacBook & Apple Watch Black Friday Deals (2019): The Top Apple Watch 5, iPhone 11, XS, MacBook Pro & iPad Pro Sales Compared by Save Bubble
Venture Capital Investment in FinTech: A Visualisation
6 Tips For Keeping Your Carpet Super Clean
Enterprise Rent-A-Car Smashes Children In Need Fundraising Target Thanks to Bespoke Donation Solution
Pourquoi le standard PCI DSS est-il incontournable pour fiabiliser les transactions en ligne dans le secteur du tourisme
The Best iMac & Mac Black Friday & Cyber Monday Deals (2019): List of Apple Mac & iMac Mini, Pro Savings Shared by The Consumer Post
Investors’ confidence in P2P lending is growing in Europe
Here’s the Best Android Smartphone Black Friday & Cyber Monday 2019 Deals: List of Moto, OnePlus, LG, HTC, Pixel & Galaxy Cell Phone Sales Listed by Consumer Walk
Top Benefits of Insulated Buildings for Heat and Cool Your Home
Follow our Tweets
Business Wire6 days ago
HTC Vive, Oculus Rift, Samsung Gear & PSVR Cyber Monday Deals (2019): Top VR Headset Sales Researched by The Consumer Post
Business Wire6 days ago
Monitor Cyber Monday Deals (2019): Top Samsung, Acer, ASUS, HP, G-Sync & LG Monitor Sales Researched by Consumer Articles
IT7 days ago
VirtualArmour Reports Q3 2019 Results; Services Revenue Exceeds Product Sales Revenue For First Time
IT7 days ago
betterU Education Corp. Announces Results for the Quarter Ended September 30, 2019
Business Wire7 days ago
Gannett Media Corp., a Subsidiary of Gannett Co., Inc., Announces Fundamental Change Company Notice and Offer to Repurchase for Cash Relating to its 4.750% Convertible Senior Notes due 2024
Business Wire6 days ago
Samsung Galaxy (Note10, S10, S9) Cyber Monday 2019 Deals: All the Best Samsung Galaxy Smartphone Sales Rounded Up by Deal Tomato
Business Wire6 days ago
GoPro Cyber Monday Deals 2019: The Best GoPro HERO8, 7, 6 & 5 Action Camera Deals Reviewed by Consumer Walk
Business Wire7 days ago
ALTRIA GROUP 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Altria Group, Inc. – MO